Dinaciclib in Treating Patients With Stage III-IV Melanoma

Summary

This is a phase I/II trial is studying the side effects and best dose of dinaciclib and to see how well it works in treating patients with advanced melanoma. Dinaciclib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Timeline

Start

2009-09

Primary completion

2014-10

Completion

2014-10

Drugs

Indications